Literature DB >> 8412014

Abnormalities of biogenic amine metabolism.

K Hyland1.   

Abstract

The term biogenic amine is an umbrella term that encompasses all amines with an origin in biological processes. This review will be restricted to the biogenic amine abnormalities that affect the metabolism of serotonin and the catecholamines. The synthesis and catabolism of these neurotransmitters are outlined, and a summary is given of the neurological details, biochemical features, and treatment of the inborn errors that primarily affect their metabolism. An idea is also developed that proposes that abnormalities of biogenic amine metabolism are far more common than is currently considered, and that the search for these problems may be appropriate in any neonate or infant who presents with neurological problems of unknown origin.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8412014     DOI: 10.1007/bf00711900

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  43 in total

1.  A method for the measurement of S-adenosylmethionine in small volume samples of cerebrospinal fluid or brain using high-performance liquid chromatography-electrochemistry.

Authors:  R Surtees; K Hyland
Journal:  Anal Biochem       Date:  1989-09       Impact factor: 3.365

2.  Cerebrospinal fluid neurotransmitter metabolites in neurologically normal infants and children.

Authors:  P J Langlais; F X Walsh; E D Bird; H L Levy
Journal:  Pediatrics       Date:  1985-03       Impact factor: 7.124

3.  Dopa and 3-O-methyldopa in cerebrospinal fluid of Parkinsonism patients during treatment with oral L-dopa.

Authors:  N S Sharpless; D S McCann
Journal:  Clin Chim Acta       Date:  1971-01       Impact factor: 3.786

4.  Tetrahydropterin therapy for hyperphenylalaninemia caused by defective synthesis of tetrahydrobiopterin.

Authors:  S Kaufman; G Kapatos; W B Rizzo; J D Schulman; L Tamarkin; G R Van Loon
Journal:  Ann Neurol       Date:  1983-09       Impact factor: 10.422

Review 5.  Biosynthesis and metabolism of tetrahydrobiopterin and molybdopterin.

Authors:  C A Nichol; G K Smith; D S Duch
Journal:  Annu Rev Biochem       Date:  1985       Impact factor: 23.643

Review 6.  Analysis and clinical significance of pterins.

Authors:  K Hyland; D W Howells
Journal:  J Chromatogr       Date:  1988-07-29

7.  Letter: A new molecular defect in phenylketonuria.

Authors:  K Bartholome
Journal:  Lancet       Date:  1974-12-28       Impact factor: 79.321

8.  Developmental aspects of pteridine metabolism and relationships with phenylalanine metabolism.

Authors:  J L Dhondt; P Ardouin; J M Hayte; J P Farriaux
Journal:  Clin Chim Acta       Date:  1981-10-26       Impact factor: 3.786

9.  Reduced cerebrospinal fluid 5-hydroxyindoleacetic acid and homovanillic acid in children with epilepsy.

Authors:  B A Shaywitz; D J Cohen; M B Bowers
Journal:  Neurology       Date:  1975-01       Impact factor: 9.910

10.  Congenital dopamine-beta-hydroxylase deficiency. A novel orthostatic syndrome.

Authors:  A J Man in 't Veld; F Boomsma; P Moleman; M A Schalekamp
Journal:  Lancet       Date:  1987-01-24       Impact factor: 79.321

View more
  6 in total

Review 1.  Neurochemistry and defects of biogenic amine neurotransmitter metabolism.

Authors:  K Hyland
Journal:  J Inherit Metab Dis       Date:  1999-06       Impact factor: 4.982

2.  Outcome of tyrosinaemia type III.

Authors:  C J Ellaway; E Holme; S Standing; M A Preece; A Green; E Ploechl; M Ugarte; F K Trefz; J V Leonard
Journal:  J Inherit Metab Dis       Date:  2001-12       Impact factor: 4.982

3.  Atypical vitamin B12-unresponsive methylmalonic aciduria in sibship with severe progressive encephalomyelopathy: a new genetic disease?

Authors:  E Mayatepek; G F Hoffmann; R Baumgartner; A Schulze; C Jakobs; F K Trefz; H J Bremer
Journal:  Eur J Pediatr       Date:  1996-05       Impact factor: 3.183

4.  Neurotransmitter metabolites in CSF: an external quality control scheme.

Authors:  C Bräutigam; C Weykamp; G F Hoffmann; R A Wevers
Journal:  J Inherit Metab Dis       Date:  2002-08       Impact factor: 4.982

5.  Tetrahydrobiopterin deficiencies: Lesson from clinical experience.

Authors:  Ayse Ergul Bozaci; Esra Er; Havva Yazici; Ebru Canda; Sema Kalkan Uçar; Merve Güvenc Saka; Cenk Eraslan; Hüseyin Onay; Sara Habif; Beat Thöny; Mahmut Coker
Journal:  JIMD Rep       Date:  2021-02-01

6.  Depletion of serotonin in the basolateral amygdala elevates glutamate receptors and facilitates fear-potentiated startle.

Authors:  L Tran; B K Lasher; K A Young; N B Keele
Journal:  Transl Psychiatry       Date:  2013-09-03       Impact factor: 6.222

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.